Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Medtech SAS updates on initial public offering


Friday, 20 Dec 2013 02:30am EST 

Medtech SAS:Says Natixis and Oddo, joint lead managers and bookrunners of the company's initial public offering, did not exercise the over-allotment option.Says this means the final sum raised in the IPO is 20,000,007 euros, represented by 740,741 new shares.